Neuroprotective effect of valsartan versus pramipexole on mouse model of MPTP-induced Parkinson’s disease
Introduction: Parkinson’s disease is the second most common complex progressive neurodegenerative disease after Alzheimer’s disease. Tremor, stiffness, and bradykinesia are common symptoms, additionally to postural instability as the condition advances. Valsartan is prescribed to treat hypertension...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Belgorod National Research University
2025-12-01
|
| Серии: | Research Results in Pharmacology |
| Предметы: | |
| Online-ссылка: | https://rrpharmacology.ru/index.php/journal/article/view/588 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
